Results 261 to 270 of about 542,433 (374)

The promise of rituximab in connective tissue disease-associated interstitial lung disease. [PDF]

Afr J Thorac Crit Care Med
Wong ML.
europepmc   +1 more source

A PANoptosis‐Based Signature for Survival and Immune Predication in Glioblastoma Multiforme

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective PANoptosis is a concept of total cell death characterized by pyroptosis, apoptosis, and necroptosis. We aimed to explore the clinical significance of PANoptosis‐related genes (PARGs) in glioblastoma multiforme (GBM). Methods Expression profiles of GBM were downloaded from the XENA database as a training dataset to construct a ...
Jun Yang, Da Lin, Dongyuan Liu, Dongxu Zhang, Hao Wang   +4 more
wiley   +1 more source

Pulmonary rehabilitation in connective tissue disease-associated interstitial lung disease: A systematic review. [PDF]

Sarcoidosis Vasc Diffuse Lung Dis
Seleoglu I, Demirel A.
europepmc   +1 more source

Autoimmunity to a 28–30 kD cell membrane DNA binding protein: occurrence in selected sera from patients with SLE and mixed connective tissue disease (MCTD)

, 1991
Robert M. Bennett, Ken Cornell, M J MERRITT, Antony C. Bakke, Ping‐Ning Hsu, Steven H. Hefeneider   +5 more
openalex   +2 more sources

Determinants of Self‐Management Behavior in Gout: A Scoping Review

Arthritis Care &Research, Volume 77, Issue 4, Page 534-544, April 2025.
Objective This study aimed to identify modifiable determinants of self‐management behavior in patients with gout. Methods Four databases (Medline, Embase, PsycINFO, and CINAHL) were searched using terms related to gout, self‐management, and determinants of behavior as described in the Theoretical Domains Framework (TDF).
Jeffrey van der Ven, Bart J. F. van den Bemt, Marcel Flendrie, Johanna E. Vriezekolk, Lise M. Verhoef   +4 more
wiley   +1 more source

Atypical Combination of Mixed Connective Tissue Disease and Multicentric Castleman Disease. [PDF]

Cureus
Saparov D, Gold-Olufadi S, Wasifusddin M, Hakobyan N, Uche I, Becerra H, Barakat P, Yadav R, Pokhrel A, Boris A, Wang J.   +10 more
europepmc   +1 more source

Pharmacokinetics, Efficacy, and Safety of Upadacitinib in Pediatric Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis: An Interim Analysis of an Open‐Label, Phase 1 Trial

Arthritis Care &Research, Volume 77, Issue 5, Page 584-593, May 2025.
Objective This work aimed to evaluate the pharmacokinetics, efficacy, and safety of upadacitinib, an oral selective JAK inhibitor, in pediatric patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods In an open‐label, phase 1 study (SELECT‐YOUTH), enrolled patients, aged 2 to <18 years with pcJIA, received body weight–based ...
Hermine I. Brunner, Anna Shmagel, Gerd Horneff, Ivan Foeldvari, Jordi Antón, Athimalaipet V. Ramanan, Yuli Qian, Kristina Unnebrink, Shuai Hao, Heidi S. Camp, Nasser Khan, Wei Liu, Mohamed‐Eslam F. Mohamed   +12 more
wiley   +1 more source

Connective tissue disease is associated with the risk of posterior reversible encephalopathy syndrome following lung transplantation in Korea. [PDF]

Acute Crit Care
Kim TJ, Lee HJ, Park S, Ko SB, Park SH, Yoon SH, Na KJ, Park IK, Kang CH, Kim YT, Choi SM, Park J, Kim JY, Lee HY.   +13 more
europepmc   +1 more source

The Concept of Connective-Tissue Disease [PDF]

Circulation, 1962
openaire   +3 more sources

Incidence of and Risk of Mortality After Hip Fractures in Rheumatoid Arthritis Relative to the General Population

Arthritis Care &Research, Volume 77, Issue 5, Page 604-613, May 2025.
Objective Osteoporosis, a known complication of rheumatoid arthritis (RA), increases the risk of hip fracture, which is associated with high morbidity and mortality. Fracture risk estimates in patients with RA treated with contemporary treatment strategies are lacking.
C. Allyson Jones, Pierre Guy, Hui Xie, Eric C. Sayre, Kai Zhao, Diane Lacaille   +5 more
wiley   +1 more source